Trumenba

BIOLOGICAL3 trials

Sponsors

Pfizer, Emory University

Conditions

Meningococcal VaccineNeisseria Meningitidis

Phase 3

MenABCWY Noninferiority Study in Healthy Participants ≥10 to <26 Years of Age

CompletedNCT04440163

PfizerMeningococcal Vaccine

Start: 2020-06-17End: 2022-07-24Updated: 2023-04-18

Phase 4

Trial to Describe the Safety, Tolerability, and Immunogenicity of Trumenba When Administered to Immunocompromised Participants ≥10 Years of Age

CompletedNCT04893811

PfizerMeningococcal Vaccine

Start: 2021-08-18End: 2023-09-06Updated: 2024-10-16

MenB-FHbp or MenACWY-TT/MenB-FHbp Vaccine in MenB-4C Primed Young Adults

RecruitingNCT07197762

Emory UniversityNeisseria Meningitidis

Start: 2025-11-04End: 2026-12-31Target: 125Updated: 2025-12-22